Replies to post #39492 on Humanigen Inc (HGENQ)

[cowtown jay]

Welcome to the room, horselover45.

I hope that trial data from both the PREACH-M and the ACTIV-5 trials will be used to supplement the safety and efficacy levels for lenz that the FDA wants to see, to award our EUA for covid, in addition to obtaining approval from Australia to treat CMML, and maybe even get a Priority Review Voucher.

If a partnership is a fallback position for management, I'd hate to see them forced into it. But the keystone is the regulatory approval/authorization we need to commercialize lenz.

I'm excited about management's execution of their Nasdaq compliance plan.